MASSI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 30.197
EU - Europa 20.369
AS - Asia 14.373
SA - Sud America 1.886
AF - Africa 474
OC - Oceania 337
Continente sconosciuto - Info sul continente non disponibili 10
Totale 67.646
Nazione #
US - Stati Uniti d'America 29.880
RU - Federazione Russa 6.352
PL - Polonia 4.788
SG - Singapore 4.109
CN - Cina 3.379
IT - Italia 2.448
HK - Hong Kong 2.075
IE - Irlanda 1.569
BR - Brasile 1.476
VN - Vietnam 1.439
KR - Corea 1.245
SE - Svezia 1.238
DE - Germania 847
FI - Finlandia 688
UA - Ucraina 678
FR - Francia 660
GB - Regno Unito 549
IN - India 531
AU - Australia 330
JO - Giordania 214
BD - Bangladesh 207
TR - Turchia 207
ID - Indonesia 202
CA - Canada 186
JP - Giappone 157
AR - Argentina 155
NL - Olanda 140
CH - Svizzera 105
IQ - Iraq 96
ES - Italia 90
CI - Costa d'Avorio 77
MX - Messico 76
EC - Ecuador 72
ZA - Sudafrica 72
MA - Marocco 70
NG - Nigeria 68
PH - Filippine 60
PK - Pakistan 53
MY - Malesia 46
TH - Thailandia 45
CO - Colombia 41
IR - Iran 39
CL - Cile 37
BE - Belgio 36
TW - Taiwan 34
VE - Venezuela 34
KE - Kenya 31
UZ - Uzbekistan 31
EG - Egitto 30
SA - Arabia Saudita 30
AT - Austria 29
DZ - Algeria 24
PE - Perù 24
AE - Emirati Arabi Uniti 21
BJ - Benin 21
NP - Nepal 21
PY - Paraguay 21
KZ - Kazakistan 20
RO - Romania 19
AZ - Azerbaigian 17
SC - Seychelles 15
TN - Tunisia 15
TZ - Tanzania 15
DK - Danimarca 14
LT - Lituania 14
OM - Oman 14
AL - Albania 13
CZ - Repubblica Ceca 12
DO - Repubblica Dominicana 12
IL - Israele 12
BO - Bolivia 11
UY - Uruguay 11
BH - Bahrain 10
CR - Costa Rica 10
UG - Uganda 10
JM - Giamaica 9
KW - Kuwait 9
NO - Norvegia 9
PT - Portogallo 9
BG - Bulgaria 8
EU - Europa 8
GR - Grecia 8
CY - Cipro 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
BA - Bosnia-Erzegovina 6
PA - Panama 6
SN - Senegal 6
GE - Georgia 5
HN - Honduras 5
MT - Malta 5
TL - Timor Orientale 5
BY - Bielorussia 4
GY - Guiana 4
HR - Croazia 4
HU - Ungheria 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
QA - Qatar 4
Totale 67.578
Città #
Santa Clara 5.034
Warsaw 4.773
Ashburn 3.349
Singapore 2.899
Fairfield 2.851
Hong Kong 1.687
Dublin 1.562
Chandler 1.510
Woodbridge 1.348
Seattle 1.233
Seoul 1.214
Cambridge 1.176
Houston 1.112
Jacksonville 1.092
Wilmington 1.004
San Jose 851
Hefei 843
Beijing 606
Lawrence 502
Altamura 489
Ann Arbor 489
Ho Chi Minh City 457
The Dalles 441
Princeton 427
Lauterbourg 398
Los Angeles 387
Buffalo 383
Council Bluffs 383
Hanoi 317
Melbourne 305
Boston 298
Boardman 276
Florence 273
Moscow 270
Mumbai 268
Helsinki 254
New York 234
Milan 202
Medford 199
Dallas 189
Munich 179
San Diego 174
Jakarta 136
Tokyo 132
Rome 130
Shanghai 128
Kent 121
Izmir 119
São Paulo 113
Paris 108
Bern 97
Frankfurt am Main 85
Norwalk 80
Dong Ket 78
Abidjan 77
West Jordan 76
Turku 74
Chicago 71
Clifton 71
Redondo Beach 70
London 66
Bremen 65
Orem 64
Haiphong 63
Phoenix 63
Da Nang 62
Toronto 62
Abuja 59
Chennai 57
Barcelona 48
Rio de Janeiro 48
Hillsboro 46
Montreal 46
Bengaluru 44
Falls Church 42
Guangzhou 42
Lappeenranta 42
Yubileyny 40
Brooklyn 38
Naples 38
Tianjin 38
Curitiba 36
Manchester 36
Baghdad 34
Verona 34
Andover 33
Johannesburg 33
Atlanta 32
Auburn Hills 32
Stockholm 32
Guayaquil 31
Pune 31
Brussels 30
Denver 30
Casablanca 28
Turin 28
Amman 27
Biên Hòa 26
Kuala Lumpur 26
Amsterdam 25
Totale 45.361
Nome #
Formalin safety in anatomic pathology workflow and integrated air monitoring systems for the formaldehyde occupational exposure assessment 781
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 470
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 393
Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. 333
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment 332
Droplet digital PCR (ddPCR) vs quantitative real-time PCR (qPCR) approach for detection and quantification of Merkel cell polyomavirus (MCPyV) DNA in formalin fixed paraffin embedded (FFPE) cutaneous biopsies 330
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 321
BRAF/NRAS Mutation Frequencies among Primary Tumors and Metastases in Patients with Melanoma 320
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 316
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 304
Multiparametric analysis of cell-free DNA in melanoma patients. 303
Discrepant alterations in main candidate genes among multiple primary melanomas 299
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 297
Transient Receptor Potential Vanilloid 4 (TRPV4) is Down-Regulated in Keratinocytes in Human Non-Melanoma Skin Cancer. 294
Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities 292
Integrated Akt/PKB Signaling in Immunomodulation and Its Potential Role in Cancer Immunotherapy 290
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 289
Interactive atlas of dermatoscopy. Dermoscopy: a tutorial. 285
Impact of low-thermal-injury devices on margin status in laryngeal cancer. An experimental ex vivo study 281
Expression of protease-activated receptor-1 and-2 in orofacial granulomatosis 279
Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands 277
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 275
A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging 275
KIT genetic alterations in anorectal melanomas. 263
SPECIFIC IMMUNE THERAPY-RELATED CUTANEOUS b-CELL PSEUDOLYMPHOMA WITH FOLLOWING DISSEMINATION 261
Tissue prognostic biomarkers in primary cutaneous melanoma. 261
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 258
Molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft versus host disease. 258
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. 255
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 254
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 252
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma. 251
Nras in melanoma: Targeting the undruggable target 250
Immunomodulating property of MAPK inhibitors: From translational knowledge to clinical implementation 250
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 248
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. 245
Increase in FOXP3(+) Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response 242
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 242
X-linked ichthyosis in a patient with congenital hypothyroidism 236
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 231
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study 224
A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing 219
The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma detailed analysis of 9 distinct subtypes defined by their evolutionary pathway 214
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors. 211
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 211
Recognition of Cutaneous Melanoma on Digitized Histopathological Slides via Artificial Intelligence Algorithm 210
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 208
Nevi and Breslow thickness in melanoma: sex differences? 207
Fluorescence-advanced videodermatoscopy: A promising and potential technique for the in vivo evaluation of vitiligo 207
AKT-ions with a TWIST between EMT and MET 206
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 206
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 205
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 200
Atypical Spitz tumors in patients younger than 18 years 200
Formalin safety in pathology laboratory and innovative monitoring for airborne formaldehyde exposure 199
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium 199
Detection of Merkel cell polyomavirus and human papillomavirus DNA in porocarcinoma 196
ANGIOKERATOMA CORPORIS DIFFUSUM (ANDERSON FABRY'S DISEASE): A CASE REPORT 195
EXPRESSION OF THE RETINOBLASTOMA-RELATED GENE RB2/P130 CORRELATES WITH CLINICAL OUTCOME IN ENDOMETRIAL CANCER 195
Trpa1 expression in synovial sarcoma may support neural origin 193
A blue-LED-based device for selective photocoagulation of superficial abrasions: theoretical modeling and in vivo validation 192
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo 191
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. 191
Clinical and dermoscopic features of lichenoid keratosis: A retrospective case study 190
Analysis of protease-activated receptor-1 and -2 in human scar formation. 189
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. 189
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 188
In-vivo tissue imaging using a compact mobile nonlinear microscope 188
Kaposi Sarcoma in a patient treated with Ruxolitinib 188
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 188
Non-linear laser imaging of skin lesions 187
Characterization of regulatory T cells in patients with dermatomyositis. 187
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 186
Primary Orbital Synovial Sarcoma Mimicking a Periocular Cyst 186
Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge 185
An Upgrade of Apparatus and Measurement Systems for Generation of Gaseous Formaldehyde: A Review 184
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 184
A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues. 183
Preoperative evaluation of tumor ploidy in endometrial cancer: an accurate tool to identify patients at risk for extrauterine disease and recurrence. 182
Melanoma of the penis: a clinical dermoscopic case study. 181
GIANT PELVIC RETROPERITONEAL LIPOSARCOMA 181
A further case of subacute prurigo-like linear IgA bullous dermatosis: growing evidence of a new subset. 181
Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. 181
Ntrk gene fusion detection in atypical spitz tumors 181
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: A pilot study. 180
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 179
CUTANEOUS MELANOMA HISTOLOGICALLY ASSOCIATED WITH A NEVUS AND MELANOMA DE NOVO HAVE A DIFFERENT PROFILE OF RISK. RESULTS FROM A CASE-CONTROL STUDY 179
Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression 179
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 179
Atypical Spitz tumours: an epidemiological, clinical and dermoscopic multicentre study with 16 years of follow-up 178
Combined non-linear laser imaging (two-photon excitation fluorescence microscopy, fluorescence lifetime imaging microscopy, multispectral multiphoton microscopy) in cutaneous tumours: first experiences 178
Multimodal fiber probe spectroscopy for tissue diagnostics applications: a combined Raman-fluorescence approachBiomedical Vibrational Spectroscopy VI: Advances in Research and Industry 177
Clinical and Dermoscopic Features of Vulvar Melanosis over the Last 20 Years 177
Polymorphisms of estrogen receptors: risk factors for invasive melanoma - a prospective study. 177
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux 176
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 176
Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience 175
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms 175
Acquired pseudoclubbing of a fingernail caused by spontaneous subungual haemangioma 175
Combined fluorescence-Raman spectroscopic setup for the diagnosis of melanocytic lesions 175
Totale 23.296
Categoria #
all - tutte 189.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 0 0 366
2021/20222.716 113 231 230 99 133 140 116 197 158 120 444 735
2022/20236.929 679 1.303 250 512 574 1.315 822 355 720 61 183 155
2023/20243.004 111 317 450 151 156 371 178 557 119 241 201 152
2024/202517.235 674 1.917 1.171 2.644 4.635 1.978 336 929 999 506 715 731
2025/202619.811 2.134 3.045 1.977 1.758 2.201 857 2.494 1.200 1.498 1.513 802 332
Totale 68.114